Login / Signup

COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study).

Arife Cimen AtalarAyşe Nur Özdağ AcarlıBetül BaykanPaolo MartellettiHayrunnisa BolayMustafa ErtaşEsme EkizoğluÖmer KaradaşBurcu PolatIşıl Yazıcı GençdalDavid Garcia AzorinDimos MitsikostasLoukia ApostolakopoulouHamit GençPınar Yalınay DikmenEsra Acıman DemirelElif Ilgaz AydınlarRabia Gökçen Gözübatık-CelikJavid ShafiyevBahar TaşdelenAynur Özge
Published in: The journal of headache and pain (2023)
The identification of two distinct phenotypes of prolonged or worsened headaches related to COVID-19 vaccination can provide valuable clinical insights. Having an awareness of the potential worsening of headaches following COVID-19 vaccination, particularly in patients with a primary headache disorder such as migraine, can help clinicians and headache experts anticipate and adjust their treatment strategies accordingly. This knowledge can aid in preplanning treatment modifications and optimize patient care.
Keyphrases
  • coronavirus disease
  • sars cov
  • healthcare
  • respiratory syndrome coronavirus
  • clinical trial
  • risk assessment
  • double blind
  • bioinformatics analysis